CRESCENDO PHARMACEUTICALS CORP
10-Q, EX-27, 2000-08-11
PHARMACEUTICAL PREPARATIONS
Previous: CRESCENDO PHARMACEUTICALS CORP, 10-Q, 2000-08-11
Next: SILVERSTREAM SOFTWARE INC, 10-Q, 2000-08-11



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS INCLUDED IN PART II, ITEM 8 OF FORM 10-Q DATED JUNE 30,
2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANICAL STATMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          42,181
<SECURITIES>                                        66
<RECEIVABLES>                                       41
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                46,946
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                  61,592
<CURRENT-LIABILITIES>                           15,317
<BONDS>                                              0
                                0
                                          0
<COMMON>                                            50
<OTHER-SE>                                      46,225
<TOTAL-LIABILITY-AND-EQUITY>                    61,592
<SALES>                                              0
<TOTAL-REVENUES>                                 4,433
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                42,764
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                               (38,331)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (38,331)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (38,331)
<EPS-BASIC>                                     (7.88)
<EPS-DILUTED>                                   (7.88)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission